Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COSIMA2: Irbesartan/HCTZ vs Valsartan/HCTZ in Hypertension
NCT00500604Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2007
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 14
01
Overview
Phase 4, randomised, open-label trial of irbesartan + hydrochlorothiazide in hypertension (HTN) (2 arms), sponsored by Sanofi. Primary endpoint: Reduction in mean Systolic Blood Pressure as measured by Home Blood Pressure Monitoring at 24 weeks. Started Jul 2007; status: completed.
02
Drugs
irbesartan + hydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00500604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00500604.